Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies...

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Raf kinase inhibitory protein (RKIP), also known as phosphatidylethanolamine binding protein (PEBP), inhibits Raf and negatively regulates the Raf/MAP kinase pathway, suppressing metastasis.
• RKIP/Raf interaction is regulated by RKIP phosphorylation at Ser-153 and binding of phospholipids like DHPE to its ligand-binding domain.
• The binding properties of other potential RKIP ligands to this domain remain uncharacterized.

Purpose of the Study:

• To characterize the binding properties of potential RKIP ligands under near-physiological conditions.
• To identify novel ligands that bind to RKIP's conserved ligand binding domain.
• To investigate the functional impact of these novel ligands on RKIP activity and signaling pathways.

Main Methods:

• High-resolution heteronuclear NMR spectroscopy was employed to screen a chemical library for RKIP ligands.
• Assays were performed under near-physiological solution conditions to assess ligand binding affinity.
• The effect of identified ligands on RKIP binding to Raf-1 and RKIP phosphorylation was evaluated.

Main Results:

• Many previously proposed RKIP ligands showed no detectable binding, even at millimolar concentrations.
• Three novel ligands were identified that specifically bind to the RKIP pocket.
• Unlike DHPE, these new ligands did not affect RKIP/Raf-1 interaction or RKIP phosphorylation.
• One novel ligand exhibited off-target effects, impairing EGF-induced MAPK signaling and metabolic activity.

Conclusions:

• RKIP exhibits affinity for hydrophobic ligands, with bulky aliphatic chains being crucial for function inhibition.
• Common structural elements among the identified ligands define minimal binding requirements.
• These novel ligands serve as potential lead compounds for developing therapeutics targeting RKIP.